Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 20
2020 3711
2021 7680
2022 9523
2023 7095
2024 1939

Text availability

Article attribute

Article type

Publication date

Search Results

26,671 results

Results by year

Filters applied: . Clear all
Page 1
Recent developments in the immunopathology of COVID-19.
Zhang HP, Sun YL, Wang YF, Yazici D, Azkur D, Ogulur I, Azkur AK, Yang ZW, Chen XX, Zhang AZ, Hu JQ, Liu GH, Akdis M, Akdis CA, Gao YD. Zhang HP, et al. Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5. Allergy. 2023. PMID: 36420736 Free PMC article. Review.
At the beginning of pandemic, the European Academy of Allergy and Clinical Immunology (EAACI) developed guidelines that provided timely information for the management of allergic diseases and preventive measures to reduce transmission in the allergic clinics. The global distribut …
At the beginning of pandemic, the European Academy of Allergy and Clinical Immunology (EAACI) developed guidelines that provided timely info …
Myocarditis With COVID-19 mRNA Vaccines.
Bozkurt B, Kamat I, Hotez PJ. Bozkurt B, et al. Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20. Circulation. 2021. PMID: 34281357 Free PMC article. Review.
Although the mechanisms for development of myocarditis are not clear, molecular mimicry between the spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and self-antigens, trigger of preexisti …
Although the mechanisms for development of myocarditis are not clear, molecular mimicry between the spike protein of severe acute …
Laboratory testing for the diagnosis of COVID-19.
Lai CKC, Lam W. Lai CKC, et al. Biochem Biophys Res Commun. 2021 Jan 29;538:226-230. doi: 10.1016/j.bbrc.2020.10.069. Epub 2020 Oct 28. Biochem Biophys Res Commun. 2021. PMID: 33139015 Free PMC article. Review.
Rapid and accurate laboratory diagnosis of active COVID-19 infection is one of the cornerstones of pandemic control. ...
Rapid and accurate laboratory diagnosis of active COVID-19 infection is one of the cornerstones of pandemic control. .. …
Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273.
Teo SP. Teo SP. J Pharm Pract. 2022 Dec;35(6):947-951. doi: 10.1177/08971900211009650. Epub 2021 Apr 12. J Pharm Pract. 2022. PMID: 33840294 Review.
The United States Food and Drug Administration recently issued emergency use authorization for 2 mRNA vaccines for preventing COVID-19 disease caused by SARS-CoV-2 virus infections. BNT162b2 from Pfizer-BioNTech and mRNA-1273 by Moderna are plan …
The United States Food and Drug Administration recently issued emergency use authorization for 2 mRNA vaccines for preventing COVID- …
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O'Connell AM, Simons D, Blomquist PB, Zaidi A, Nash S, Iwani Binti Abdul Aziz N, Thelwall S, Dabrera G, Myers R, Amirthalingam G, Gharbia S, Barrett JC, Elson R, Ladhani SN, Ferguson N, Zambon M, Campbell CNJ, Brown K, Hopkins S, Chand M, Ramsay M, Lopez Bernal J. Andrews N, et al. N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2. N Engl J Med. 2022. PMID: 35249272 Free PMC article.
BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns …
BACKGROUND: A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of …
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.
We aimed to systematically review the evidence for the duration of protection of COVID-19 vaccines against various clinical outcomes, and to assess changes in the rates of breakthrough infection caused by the delta variant with increasing time since vaccinati …
We aimed to systematically review the evidence for the duration of protection of COVID-19 vaccines against various clin …
How to interpret and use COVID-19 serology and immunology tests.
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Ong DSY, et al. Clin Microbiol Infect. 2021 Jul;27(7):981-986. doi: 10.1016/j.cmi.2021.05.001. Epub 2021 May 8. Clin Microbiol Infect. 2021. PMID: 33975005 Free PMC article. Review.
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detectable antibodies. ...Combining molecular diagnostics with serological tests may optimize the detection of COVID-19. As not all …
T-cell responses against SARS-CoV-2 have also been detected in recovered COVID-19 patients with no detect …
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues.
Polykretis P, Donzelli A, Lindsay JC, Wiseman D, Kyriakopoulos AM, Mörz M, Bellavite P, Fukushima M, Seneff S, McCullough PA. Polykretis P, et al. Autoimmunity. 2023 Dec;56(1):2259123. doi: 10.1080/08916934.2023.2259123. Autoimmunity. 2023. PMID: 37710966 Free article. Review.
As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to …
As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccinat …
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vax …
To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent …
26,671 results
You have reached the last available page of results. Please see the User Guide for more information.